Navigation Links
IPC The Hospitalist Company, Inc. to Report First Quarter 2009 Financial Results
Date:4/20/2009

NORTH HOLLYWOOD, Calif., April 20 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice company, announced today that it will report results for its first quarter ended March 31, 2009 on May 4, 2009, after the market close.

A conference call to review the results will begin at 5:00 p.m. ET (2:00 p.m. PT) on May 4, 2009 and will be hosted by Adam Singer, Chairman, Chief Executive Officer, and Chief Medical Officer, Jeff Taylor, President and Chief Operating Officer, and Devra Shapiro, Chief Financial Officer.

To participate in the conference call, please dial 877-723-9517 (USA) or 719-325-4815 (International). In addition, a dial-up replay of the conference call will be available beginning May 4, 2009 at 8:00 p.m. ET (5:00 p.m. PT) and ending on May 18, 2009. The replay telephone number is 888-203-1112 (USA) or 719-457-0820 (International). The replay passcode is 9468818.

A live webcast of the call will also be available from the Investor Relations section on the corporate web site at http://www.hospitalist.com. A webcast replay can be accessed on the corporate web site beginning May 4, 2009 at approximately 8:00 p.m. ET (5:00 p.m. PT) and will remain available until May 18, 2009 at 11:59 p.m.

About IPC The Hospitalist Company

IPC The Hospitalist Company, Inc. (Nasdaq: IPCM) is a leading national hospitalist physician group practice company focused on the delivery of hospitalist medicine services. IPC's physicians and affiliated providers manage the care of hospitalized patients in
'/>"/>

SOURCE IPC The Hospitalist Company, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. IPC The Hospitalist Company Presents IPC Hospitalist of the Year Award to Tim Osonma, M.D.
2. IPC The Hospitalist Company Acquires Arizona Practice
3. Spokane Hospitals Engage Sound Inpatient Physicians(TM) as Hospitalists in Spokane
4. IPC The Hospitalist Company Adopts E-Proxy to Reduce Environmental Impact
5. IPC The Hospitalist Company Reports Record Fourth Quarter and Full Year 2008 Results
6. IPC The Hospitalist Company Receives Best IPO Award from Los Angeles Venture Association
7. IPC The Hospitalist Company Acquires Missouri Practice Group
8. IPC The Hospitalist Company, Inc. to Present at 27th Annual J.P. Morgan Healthcare Conference
9. Physician Staffing Trends and Hospitalist Jobs Fuel Growth at Locum Leaders
10. IPC The Hospitalist Company Acquires Two Florida Practices
11. Dr. Steven Liu, Founder of Ingenious Med, Recognized as a Leading Hospitalist by the American College of Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 2015 The panel of independent experts ... 98 candidates short-listed for the awards presented tonight at ... was fierce but the best-of-the-best can now be revealed ... Group , Volvo swept rivals aside by taking the ... unanimous praise from our panel of expert judges., Stand ...
(Date:6/3/2015)... PA (PRWEB) June 03, 2015 Sitting ... can cause discomfort in the back, neck, shoulders and/or ... other musculoskeletal injuries. In addition, recent research links sitting ... number of chronic diseases. Fortunately, three inventors from Oakville, ... sit at a desk. , They have developed a ...
(Date:6/3/2015)... NY (PRWEB) June 03, 2015 Acne is ... (“bacne”) can be particularly stubborn to eliminate and hard to ... most common in teens and young adults, in the years ... produce sebum, or oil,” says Jayme Bashian, director and lead ... characteristic pimples, blackheads and cysts of acne are caused by ...
(Date:6/3/2015)... These are challenging and unpredictable times for traditional organizations ... business are rewriting the rules for business as we ... traditional businesses to take on a more agile approach ... On top of this there is a growing ... bring new innovation and approaches to business. , The ...
(Date:6/3/2015)... “ Scanalytics ” was featured on NewsWatch as ... latest and coolest technology products available to consumers. Andrew ... conducted the review and shared with viewers how this ... stores. , Tracking statistics in business is invaluable in ... retail this goes a step beyond revenue statistics and ...
Breaking Medicine News(10 mins):Health News:TU-Automotive Awards 2015 winners revealed 2Health News:TU-Automotive Awards 2015 winners revealed 3Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:Back Acne: Tips for Clearer Summer Skin 2Health News:Back Acne: Tips for Clearer Summer Skin 3Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2
... benefits of short-term use of hormone therapy in menopausal women ... of life, but they may also shorten their life expectancy ... not to use hormone therapy can be a difficult decision. ... but are the risks worth the benefits? Question researchers . ...
... awareness is needed about the risks of certain prescribed drugs ... // multiple chronic conditions and take several drugs concurrently many ... ,Researchers conducted a study to look at medication prescriptions ... more than 20 percent of the people filled a prescription ...
... with hemophilia arthropathy, a severe form of hemophilia that ... // than other children for developing osteoporosis in ... in preventing osteoporosis from hitting these children, say researchers. ... activities than was previously advised by doctors. An exercise ...
... a tracheoesophageal puncture (TEP), is an incision between the ... small plastic //or silicone valve , researchers say this ... and neck cancer patients who have had their voice ... combined with post operative speech rehabilitation therapy, can provide ...
... have now found a way to genetically engineer the common ... healthy ones intact.// They did this by modifying one gene, ... had to boost the activity of another gene to ensure ... say, “When the virus infects cells, it takes the altered ...
... get a prescription for a potentially lifesaving drug after ... which the heart has trouble pumping blood. // ... who don’t receive an angiotensin-converting enzyme inhibitor are 14-percent ... who do get the drug. ACE inhibitors work by ...
Cached Medicine News:
(Date:6/3/2015)...  (AHIP Institute Booth 1021) --  Availity , the ... a wide range of information to help health plans ... Health Insurance Plan,s (AHIP,s) 2015 Institute , June 3-5, ... Availity released a special report to AHIP Institute ... opportunities." The report identifies billions of dollars ...
(Date:6/3/2015)... MARLBOROUGH, Mass. , June 3, 2015 ... RXII ), a biotechnology company focused on ... the areas of dermatology and ophthalmology, today announced ... from the United States Patent and Trademark ... platform (sd‑rxRNA®). The patent, titled "RNA Interference ...
(Date:6/3/2015)... 3, 2015  EIP Pharma LLC ( www.eippharma.com ) ... development of VX-745 in Alzheimer,s disease (AD) is underway.  ... potent inhibitor of the alpha isoform of the protein ... "Recent human genetic data demonstrate that inflammation ... symptomatic Alzheimer,s, while the science also indicates the p38 ...
Breaking Medicine Technology:Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 2Availity to Share Insights, Tools and Strategies at AHIP 2015 to Enable Health Plans to Achieve Long-term, Sustainable Success in an Evolving Value-based Environment 3RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 2RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 3RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 4EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 3
... InfuSystem Holdings, Inc. (NYSE MKT: INFU) ("InfuSystem" or ... related services, today announced that it received a letter ... Amex of the "record date" for the 2012 Annual ... the record date for the Company,s 2012 Annual Meeting, ...
... (NASDAQ: ROCM ) is pleased to announce an addition ... of the Magic3 Hydrophilic Intermittent Catheter with Coude Tip ... very latest Magic3 technology. It provides the ... designed curved tip configuration. The Coude tip is ...
Cached Medicine Technology:InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders 2Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter 2
4 mm x 9 mm tip....
Large. Double-ended. 3 mm pointed end and 5 mm angled end....
4 mm wide tip....
Double-ended. Blunt and semi sharp 5 mm tips. Designated most popular model or size....
Medicine Products: